#USA #Las Vegas #VIVA Foundation #Vascular Medicine #VEINS 2026

Vascular Innovation Takes Center Stage at The VEINS and VIVA 2026

The prestigious VEINS and VIVA 2026 conferences, hosted by the VIVA Foundation, are set to illuminate the latest advances in vascular medicine from October 3-6 at the Bellagio Las Vegas. With a lineup of 26 clinical trials, these events promise to unveil cutting-edge research that could significantly reshape vascular care for patients worldwide.

For the past 24 years, VIVA (Vascular InterVentional Advances) has established itself as a leader in clinical education regarding peripheral vascular diseases. The focus has always been on delivering the most relevant practice-changing data, and this year's event will follow suit. VIVA uniquely combines some of the most recent scientific discoveries, innovative technologies, and insights from globally recognized experts in the field.

Complementing VIVA is The VEINS (Venous Endovascular INterventional Strategies) conference, which specifically targets venous disorders. Together, they provide a holistic educational experience spanning the entire spectrum of vascular health.

An international faculty consisting of specialists from various disciplines will lead live demonstrations, interactive workshops, and in-depth expert discussions. This unique setup will ensure that attendees gain unparalleled access to groundbreaking clinical trial outcomes, which can facilitate enhanced treatment options for vascular diseases.

Clinical Trial Highlights

The schedule is packed with essential clinical presentations, including:
1. Prospective Clinical Trial Evaluating Cyanoacrylate Closure in patients with the C6 disease spectrum presented by Dr. Manj Gohel.
2. Interim Results of the BERG02 Study, focusing on percutaneous ligation combined with sclerotherapy by Dr. Steve Elias.
3. 30-Day Results from the Registry of the Abre Venous Stent System, shared by Dr. Paul Gagne.
4. Safety and Efficacy of Mechanical Thrombectomy in deep vein thrombosis as unveiled by Dr. Patrick E. Muck.
5. Effects of Iliac Vein Stent Placement on quality of life discussed by Dr. Suresh Vedantham.

Each of these presentations provides insights into the latest treatment protocols and outcomes, reflecting the rapidly evolving landscape of vascular medicine.

Among the significant findings will be results that substantiate treatment effectiveness and patient welfare outcomes. Notably, the meeting will also address essential topics like the predictors of major bleeding in pulmonary embolism patients, which is crucial for adjusting clinical approaches going forward.

Registration and Attendance

Media representatives and healthcare professionals interested in the advancements of vascular medicine are encouraged to attend either in person or through virtual platforms. The full agenda detailing all sessions, presenters, and transcending discussions is accessible on the official VIVA Foundation website.

The VIVA Foundation, a nonprofit organization committed to the progression of vascular medicine through education and research, will leverage this conference to unite healthcare professionals dedicated to improving patient outcomes in vascular diseases.

This collaborative effort aims not just to inform, but to transform the practices and strategies applied in vascular health, ensuring that both current and future patients benefit from the cutting-edge innovations being discussed.

In closing, the VEINS and VIVA 2026 events reflect a commitment to continuous improvement in vascular care, positioning attendees at the forefront of clinical excellence. As the field of vascular medicine evolves, conferences like these play an essential role in fostering dialogue, education, and collaborative growth within the medical community.